Le He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Le He has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Min Sun
East China University of Science and Technology
5 shared publications - Zhen Fan
Tongji University 4800 Caoan Road
5 shared publications - Jianzhong Du
East China University of Science and Technology
4 shared publications - Zhenghong Ge
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
3 shared publications - Fanying Meng
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
2 shared publications - Jiaxi Xu
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
2 shared publications
Latest Publications
- 29 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (31) , 43518-43519
Correction to “Peptide Hydrogels for Renal Carcinoma Therapy via Synergistic Inhibition of Glycolysis and Mitochondrial Metabolism Reprogramming”
- 29 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (31) , 43518-43519
Correction to “Peptide Hydrogels for Renal Carcinoma Therapy via Synergistic Inhibition of Glycolysis and Mitochondrial Metabolism Reprogramming”
- 23 August 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (35) , 13284-13293
Machine Learning-Assisted Real-Time Inflammation Monitoring and Optimal Treatment of Diabetic Wounds Based on a Ratiometric Fluorescent Sensing Peptide Hydrogel
Managing inflammation in diabetic chronic wounds remains a major clinical challenge, primarily due to the lack of real-time monitoring techniques. To address this issue, we developed a peptide hydrogel capable of simultaneously monitoring the inflammation status and promoting healing. The hydrogel was formed by coassembling polyglutamic acid with polylysine that was premodified with coumarin 7 (an ACQ fluorophore) and tetraphenylethene (an AIE fluorophore). In the inflammatory microenvironment, released fluorophores undergo colorimetric changes that enable semiquantitative detection of reactive oxygen species (ROS). Leveraging this response, we imaged 1500 wound areas from mouse skin samples exhibiting varying ROS concentrations to create a training data set for the K-Nearest Neighbors (KNN) model, which allows real-time calculation of in situ ROS levels. Crucially, treatment strategies were dynamically adjusted based on such calculated ROS levels. Collectively, this system represents a promising approach for real-time inflammation monitoring and toward closed-loop therapy.
- 23 August 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (35) , 13284-13293
Machine Learning-Assisted Real-Time Inflammation Monitoring and Optimal Treatment of Diabetic Wounds Based on a Ratiometric Fluorescent Sensing Peptide Hydrogel
Managing inflammation in diabetic chronic wounds remains a major clinical challenge, primarily due to the lack of real-time monitoring techniques. To address this issue, we developed a peptide hydrogel capable of simultaneously monitoring the inflammation status and promoting healing. The hydrogel was formed by coassembling polyglutamic acid with polylysine that was premodified with coumarin 7 (an ACQ fluorophore) and tetraphenylethene (an AIE fluorophore). In the inflammatory microenvironment, released fluorophores undergo colorimetric changes that enable semiquantitative detection of reactive oxygen species (ROS). Leveraging this response, we imaged 1500 wound areas from mouse skin samples exhibiting varying ROS concentrations to create a training data set for the K-Nearest Neighbors (KNN) model, which allows real-time calculation of in situ ROS levels. Crucially, treatment strategies were dynamically adjusted based on such calculated ROS levels. Collectively, this system represents a promising approach for real-time inflammation monitoring and toward closed-loop therapy.
- 16 June 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (25) , 36487-36496
Peptide Hydrogels for Renal Carcinoma Therapy via Synergistic Inhibition of Glycolysis and Mitochondrial Metabolism Reprogramming
The pathogenesis of renal cell carcinoma (RCC) is intricately associated with metabolic reprogramming as a key characteristic of cancer malignancy. This study presents a peptide-based hydrogel platform to disrupt tumor metabolic plasticity by simultaneously targeting oxidative phosphorylation (OXPHOS) and glycolysis. The hydrogels were synthesized through the self-assembly of 9-fluorenylmethoxycarbonyl-modified diphenylalanine (Fmoc-FF), followed by electrostatic complexation with glycol chitosan (GCS). The hydrophobic OXPHOS inhibitor Oligomycin A (Oligo) and the hydrophilic glycolysis inhibitor 2-deoxy-d-glucose (2-DG) were efficiently co-loaded into the peptide hydrogels. In vitro studies revealed that monotherapy with either Oligo or 2-DG is limited by compensatory metabolic rewiring as tumor cells switch between glycolysis and OXPHOS to maintain energy homeostasis. In contrast, dual inhibition induced synthetic lethality, disrupting cellular energy homeostasis and activating apoptotic pathways. Our findings validate the potential of integrating mitochondrial bioenergetic disruption with glycolytic inhibition in a single and orally administered delivery system. In vivo evaluation in RCC xenografts demonstrated that oral hydrogel codelivery of Oligo and 2-DG achieved potent tumor suppression with minimal systemic toxicity. By integrating tumor-selective delivery, dual metabolic targeting, and oral administration, this work presents a transformative strategy to address metabolic heterogeneity and clinical toxicity, offering a versatile platform for precision cancer therapy.
- 16 June 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (25) , 36487-36496
Peptide Hydrogels for Renal Carcinoma Therapy via Synergistic Inhibition of Glycolysis and Mitochondrial Metabolism Reprogramming
The pathogenesis of renal cell carcinoma (RCC) is intricately associated with metabolic reprogramming as a key characteristic of cancer malignancy. This study presents a peptide-based hydrogel platform to disrupt tumor metabolic plasticity by simultaneously targeting oxidative phosphorylation (OXPHOS) and glycolysis. The hydrogels were synthesized through the self-assembly of 9-fluorenylmethoxycarbonyl-modified diphenylalanine (Fmoc-FF), followed by electrostatic complexation with glycol chitosan (GCS). The hydrophobic OXPHOS inhibitor Oligomycin A (Oligo) and the hydrophilic glycolysis inhibitor 2-deoxy-d-glucose (2-DG) were efficiently co-loaded into the peptide hydrogels. In vitro studies revealed that monotherapy with either Oligo or 2-DG is limited by compensatory metabolic rewiring as tumor cells switch between glycolysis and OXPHOS to maintain energy homeostasis. In contrast, dual inhibition induced synthetic lethality, disrupting cellular energy homeostasis and activating apoptotic pathways. Our findings validate the potential of integrating mitochondrial bioenergetic disruption with glycolytic inhibition in a single and orally administered delivery system. In vivo evaluation in RCC xenografts demonstrated that oral hydrogel codelivery of Oligo and 2-DG achieved potent tumor suppression with minimal systemic toxicity. By integrating tumor-selective delivery, dual metabolic targeting, and oral administration, this work presents a transformative strategy to address metabolic heterogeneity and clinical toxicity, offering a versatile platform for precision cancer therapy.
Nanoporous Plasmonic Microneedle Arrays Induced High‐Efficiency Intracellular Delivery of Metabolism Regulating Protein
Patterned micro/nanostructure arrays have shown the potential to effectively regulate cellular behavior, and their unique microstructure may address the limitations of conventional pore materials, leading to novel phenomena. In this work, a large‐area gold micro/nano‐array substrate with an average hole of ≈32 nm is designed and extensively screened. Precisely engineered nanopores on the substrate can effectively improve photothermal conversion efficiency, and instant heat dissipation in the absence of laser irradiation. The mesoporous arrays are fabricated by hybrid lithography, offering advantages such as simple processing, high reproducibility, and immense commercial potential. Notably, its heating rate is as rapid as ≈45 K µs−1 at low power levels, with the cooling duration reduced to ≈50 µs after the laser irradiation. Metabolism regulatory proteins such as cytochrome C (CytoC) and β‐galactosidase (β‐gal) can be efficiently introduced into the U87 cell model without inducing phototoxicity or protein inactivation, maintaining catalytic activity to modulate the cellular metabolic state. This delivery platform based on transient nano‐cyclones stimulating cell perturbations can be further expanded through modulated microstructures, such as delivering functional proteins or biomolecules for efficient intracellular regulation, cellular transfection, and in the future application as a potential high‐throughput screening tool for clustered regularly interspaced short palindromic repeats (CAR‐T) biopharmaceutical and clustered regularly interspaced short palindromic repeats (CRISPR) technologies.
Nanoporous Plasmonic Microneedle Arrays Induced High‐Efficiency Intracellular Delivery of Metabolism Regulating Protein
Patterned micro/nanostructure arrays have shown the potential to effectively regulate cellular behavior, and their unique microstructure may address the limitations of conventional pore materials, leading to novel phenomena. In this work, a large‐area gold micro/nano‐array substrate with an average hole of ≈32 nm is designed and extensively screened. Precisely engineered nanopores on the substrate can effectively improve photothermal conversion efficiency, and instant heat dissipation in the absence of laser irradiation. The mesoporous arrays are fabricated by hybrid lithography, offering advantages such as simple processing, high reproducibility, and immense commercial potential. Notably, its heating rate is as rapid as ≈45 K µs−1 at low power levels, with the cooling duration reduced to ≈50 µs after the laser irradiation. Metabolism regulatory proteins such as cytochrome C (CytoC) and β‐galactosidase (β‐gal) can be efficiently introduced into the U87 cell model without inducing phototoxicity or protein inactivation, maintaining catalytic activity to modulate the cellular metabolic state. This delivery platform based on transient nano‐cyclones stimulating cell perturbations can be further expanded through modulated microstructures, such as delivering functional proteins or biomolecules for efficient intracellular regulation, cellular transfection, and in the future application as a potential high‐throughput screening tool for clustered regularly interspaced short palindromic repeats (CAR‐T) biopharmaceutical and clustered regularly interspaced short palindromic repeats (CRISPR) technologies.
- Open Access
- 1 November 2024
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 4 (11) , 4162-4186
Precise Regulations at the Subcellular Level through Intracellular Polymerization, Assembly, and Transformation
A living cell is an intricate machine that creates subregions to operate cell functions effectively. Subcellular dysfunction has been identified as a potential druggable target for successful drug design and therapy. The treatments based on intracellular polymerization, self-assembly, or transformation offer various advantages, including enhanced blood circulation of monomers, long-term drug delivery pharmacokinetics, low drug resistance, and the ability to target deep tissues and organelles. In this review, we discuss the latest developments of intracellular synthesis applied to precisely control cellular functions. First, we discuss the design and applications of endogenous and exogenous stimuli-triggered intracellular polymerization, self-assembly, and dynamic morphology transformation of biomolecules at the subcellular level. Second, we highlight the benefits of these strategies applied in cancer diagnosis and treatment and modulating cellular states or cell metabolism of living systems. Finally, we conclude the recent progress in this field, discuss future perspectives, analyze the challenges of the intracellular functional reactions for regulation, and find future opportunities.
- 1 November 2024
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 4 (11) , 4162-4186
Open AccessPrecise Regulations at the Subcellular Level through Intracellular Polymerization, Assembly, and Transformation
A living cell is an intricate machine that creates subregions to operate cell functions effectively. Subcellular dysfunction has been identified as a potential druggable target for successful drug design and therapy. The treatments based on intracellular polymerization, self-assembly, or transformation offer various advantages, including enhanced blood circulation of monomers, long-term drug delivery pharmacokinetics, low drug resistance, and the ability to target deep tissues and organelles. In this review, we discuss the latest developments of intracellular synthesis applied to precisely control cellular functions. First, we discuss the design and applications of endogenous and exogenous stimuli-triggered intracellular polymerization, self-assembly, and dynamic morphology transformation of biomolecules at the subcellular level. Second, we highlight the benefits of these strategies applied in cancer diagnosis and treatment and modulating cellular states or cell metabolism of living systems. Finally, we conclude the recent progress in this field, discuss future perspectives, analyze the challenges of the intracellular functional reactions for regulation, and find future opportunities.